Background Antimicrobial resistance (AMR) is one of the biggest threats to global public
health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst …

Community‐acquired pneumonia (CAP) is a common cause of morbidity and mortality in
adults worldwide, but its epidemiology varies markedly by region. Whilst in high‐income …

Objectives Antibiotic therapy is widely used for patients with community-acquired
pneumonia (CAP), and yet whether the efficacy of antibiotics differs based on the treatment …

Purpose Community-acquired pneumonia (CAP) is common among the elderly; it typically
has a poor prognosis and high mortality. This study evaluated the factors predicting CAP …

Pneumonia remains a major global health challenge, necessitating the development of
effective therapeutic approaches. Recently, necroptosis, a regulated form of cell death, has …

Objective Fluoroquinolones and 3rd-generation cephalosporins that are prescribed for
pneumonia may be avoided and replaced by a penicillin in some cases. We aimed to …

Цель работы сопоставление частоты применения антибактериальных средств с
данными отечественных и зарубежных исследований, а также полученными в …

Tóm tắt Đặt vấn đề: Sử dụng hợp lý kháng sinh trong điều trị viêm phổi cộng đồng (VPCĐ)
giữ vai trò rất quan trọng giúp kiểm soát bệnh. Mục tiêu: Khảo sát việc sử dụng kháng sinh …

Angka kematian Community-Acquired Penumonia (CAP) di Indonesia menduduki peringkat
keempat dari sepuluh penyakit terbanyak tiap tahun. Prinsip terapi utama CAP adalah …

Globally, community-acquired pneumonia (CAP) occurs in 1-10%. No specific statistics are
available for Low and Middle Income Countries (LMIC). Diagnosis of CAP is suspected …